Sugano Mikio, Murata Masaya, Ide Yujiro, Ito Hiroki, Kanno Kazuyoshi, Imai Kenta, Ishidou Motonori, Fukuba Ryohei, Sakamoto Kisaburou
Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, 860 Urushiyama, Aoi-ku, Shizuoka, Shizuoka, 420-8660, Japan.
Gen Thorac Cardiovasc Surg. 2019 Nov;67(11):941-948. doi: 10.1007/s11748-019-01141-3. Epub 2019 May 27.
To evaluate the clinical outcomes of surgical repair of an extracardiac total anomalous pulmonary venous connection (TAPVC) in a functional single-ventricle (f-SV) strategy.
This was a retrospective analysis of 48 consecutive cases of extracardiac TAPVC repair, from 1998 to 2015. Demographic and clinical variables were as follows: median age, 24 (range 0-744) days; median weight, 3.1 (range 2.0-9.6) kg; type of TAPVC-supracardiac, 21 patients, infracardiac, 8, and mixed, 19; right atrial isomerism, 45 patients; pulmonary atresia, 24 patients; and obstructed TAPVC, 30 patients. Concomitant procedures included systemic-to-pulmonary shunting in 15 patients, pulmonary artery banding in 12, ventricle-to-pulmonary artery shunting in 2, a Norwood procedure in one, a bidirectional Glenn procedure in 16, and a Fontan procedure in 1.
The 1- and 5-year cumulative survival rates were 66.0% and 58.0%, respectively. Of the 28 survivors, 22 (78.6%) underwent Fontan completion and 4 (14.3%) a bidirectional Glenn procedure, and 1 (3.6%) was awaiting a bidirectional Glenn procedure. Recurrent pulmonary venous stenosis (PVS) was observed in 17 patients, with a 1- and 5-year rates of freedom from recurrent PVS 59.8% and 53.5%, respectively. Of the 20 post-operative deaths, only 4 were PVS related. Only pre-operative pulmonary atresia was identified as an independent risk factor of mortality after TAPVC repair.
The midterm surgical outcomes of f-SV with extracardiac TAPVC were acceptable. Moreover, among survivors, Fontan completion can be sufficiently expected. Further improvement, with the development of a comprehensive treatment strategy, is required for this patient group.
评估在功能性单心室(f-SV)策略下,心外完全性肺静脉异位连接(TAPVC)手术修复的临床效果。
这是一项对1998年至2015年连续48例心外TAPVC修复病例的回顾性分析。人口统计学和临床变量如下:中位年龄24(范围0 - 744)天;中位体重3.1(范围2.0 - 9.6)千克;TAPVC类型 - 心上型21例患者,心下型8例,混合型19例;右心房异构45例患者;肺动脉闭锁24例患者;梗阻性TAPVC 30例患者。同期手术包括15例患者进行体肺分流,12例进行肺动脉环扎,2例进行心室 - 肺动脉分流,1例进行诺伍德手术,16例进行双向格林手术,1例进行Fontan手术。
1年和5年累积生存率分别为66.0%和58.0%。在28名幸存者中,22例(78.6%)接受了Fontan手术完成,4例(14.3%)进行了双向格林手术,1例(3.6%)正在等待双向格林手术。17例患者观察到复发性肺静脉狭窄(PVS),1年和5年无复发性PVS的发生率分别为59.8%和53.5%。在20例术后死亡病例中,只有4例与PVS相关。仅术前肺动脉闭锁被确定为TAPVC修复后死亡的独立危险因素。
采用f-SV策略的心外TAPVC中期手术效果可以接受。此外,在幸存者中,可以充分预期Fontan手术的完成。对于该患者群体,需要随着综合治疗策略的发展进一步改善。